Elion, Dr. Gertrude

Head, Dept. Experimental Therapy, USA

2 Items (50 Sub Items)

Copies of some of these images can be found in the MedPhoto database, references:

L0034253

L0034254

L0034255

L0034256

L0034259

During 1966 and 1986, the sales of the Wellcome Foundation grew from £32 million to over £500 million. Most of this growth can be put down to the astonishing success of Drs Hitchings and Elion, who worked for over 30 years at the Wellcome Research Laboratories in North Carolina.

During their careers, their drug discoveries (with their brand names) included:
6-mercaptopurine (Purinethol), the first treatment for leukemia.
Azathioprine (Imuran), the first immuno-suppressive agent, used for organ transplants.
Allopurinol (Zyloprim), for gout.
Pyrimethamine (Daraprim), for malaria.
Trimethoprim (Septra), for meningitis, septicemia, and bacterial infections of the urinary and respiratory tracts.
Acyclovir (Zovirax), for viral herpes.

This photograph dates from 1988, when they were jointly awarded the Nobel Prize in Physiology or Medicine.

As a result of the Wellcome Foundation's huge jump in profits, the Wellcome Trust was able to greatly increase their funding of scientific research during this period.

WF/M/I/PR/313/1 George H. Hitchings and Gertrude B. Elion, 1960s.

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.